<DOC>
	<DOC>NCT01793259</DOC>
	<brief_summary>The primary objective of this study is to assess the number of patients preferring the methotrexate pre-filled pen to the methotrexate pre-filled syringe after 6 weeks of treatment based on a questionnaire</brief_summary>
	<brief_title>Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Written informed consent Age between 18 and 75 years Rheumatoid arthritis according to the American College of Rheumatology (ACR) criteria 1987 or ACR/European Liga Against Rheumatology (EULAR)2010 Disease activity score (DAS) 28 &gt; 2.6 Main Prior or other current subcutaneous treatment with selfinjection Prior or concomitant treatment with biologics Contraindications to MTX treatment History or diagnosis of a dermatological disease at the injection site Women with childbearing potential who do not use a highly effective method of contraception or men who have a partner with childbearing potential and do not use a contraception during the study and at least 6 months thereafter.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>